2020 Undergraduate Research Showcase
 

Document Type

Student Presentation

Loading...

Media is loading
 

Presentation Date

4-24-2020

Faculty Sponsor

Dr. Julia Oxford

Abstract

Kleine Levin Syndrome (KLS), also known as Sleeping Beauty Syndrome, is characterized by progressive drowsiness and sleep for most days and nights. It is a rare neurological disorder with a prevalence of one to five cases per million. Those with KLS have recurring periods of excessive sleep, altered behavior, and a reduced understanding of the world. KLS primarily occurs in adolescents, boys more frequently than girls with a higher prevalence in Ashkenazi Jews. The exact cause of KLS is unknown but damage or malfunction of the hypothalamus may be involved. Although there is no definitive treatment for KLS, pharmaceuticals such as stimulants have been used to combat the sleepiness. However, these can cause irritability and mood swings, so alternatives to pharmaceuticals are also considered. Recent research suggests that a mutation in the gene LMOD3 may be the cause of KLS. LMOD proteins are structural proteins and appear to be developmentally regulated. In this poster, we will present the molecular mechanism for the disease and potential therapeutic targets for treatment on this disease.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.